Skip to main content
Sergei Syrbu, MD, Pathology, Iowa City, IA

SergeiISyrbuMD

Pathology Iowa City, IA

Hematopathology, Transplantation Immunology, Anatomic Pathology, Clinical Pathology

Clinical Professor, hematopathology and Immunopathology

Dr. Syrbu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Syrbu's full profile

Already have an account?

  • Office

    200 Hawkins Dr
    Iowa City, IA 52242
    Phone+1 319-356-7372
    Fax+1 319-384-8053

Education & Training

  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Pathology-Anatomic and Clinical, 1999 - 2003
  • Nicolae Testemitanu State University of Medicine and Pharmacy
    Nicolae Testemitanu State University of Medicine and PharmacyClass of 1982

Certifications & Licensure

  • IA State Medical License
    IA State Medical License 1999 - 2025
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Hematology

Publications & Presentations

PubMed

Abstracts/Posters

  • Intrafollicular CD4+ T-Cells As an Independent Predictor of Early Clinical Failure in Newly Diagnosed Follicular Lymphoma
    Sergei Syrbu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Event-Free Survival at 24 Months Following Autologous Stem Cell Transplant in Diffuse Large B-Cell Lymphoma
    Sergei Syrbu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Prevalence and the Impact of Hypogammaglobulinemia in Newly Diagnosed, Untreated Diffuse Large B Cell Lymphoma
    Sergei Syrbu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018